144 related articles for article (PubMed ID: 34313449)
21. Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.
Jensen KT; Larsen FH; Cornett C; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2015 Jul; 12(7):2484-92. PubMed ID: 26057950
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
23. Advances in coamorphous drug delivery systems.
Shi Q; Moinuddin SM; Cai T
Acta Pharm Sin B; 2019 Jan; 9(1):19-35. PubMed ID: 30766775
[TBL] [Abstract][Full Text] [Related]
24. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
[TBL] [Abstract][Full Text] [Related]
25. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
26. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
27. Predicted amorphous solubility and dissolution rate advantages following moisture sorption: Case studies of indomethacin and felodipine.
Skrdla PJ; Floyd PD; Dell'Orco PC
Int J Pharm; 2019 Jan; 555():100-108. PubMed ID: 30448307
[TBL] [Abstract][Full Text] [Related]
28. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
[TBL] [Abstract][Full Text] [Related]
29. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
[TBL] [Abstract][Full Text] [Related]
30. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
[TBL] [Abstract][Full Text] [Related]
31. Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability.
Chen X; Li D; Zhang H; Duan Y; Huang Y
Int J Pharm; 2021 Apr; 598():120389. PubMed ID: 33609724
[TBL] [Abstract][Full Text] [Related]
32. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
33. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
35. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805
[TBL] [Abstract][Full Text] [Related]
36. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
37. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
Mathers A; Hassouna F; Klajmon M; Fulem M
Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic phase behaviour of indomethacin/PLGA formulations.
Prudic A; Lesniak AK; Ji Y; Sadowski G
Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211
[TBL] [Abstract][Full Text] [Related]
39. Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone-co-vinyl acetate).
Pezzoli R; Lyons JG; Gately N; Higginbotham CL
Int J Pharm; 2018 Oct; 549(1-2):50-57. PubMed ID: 30016675
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of amorphous paracetamol based systems using traditional and novel strategies.
Martínez LM; Videa M; López-Silva GA; de Los Reyes CA; Cruz-Angeles J; González N
Int J Pharm; 2014 Dec; 477(1-2):294-305. PubMed ID: 25447825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]